Download The CRISPR-Cas technique has been used to generate gene knock

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Community fingerprinting wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Cell-penetrating peptide wikipedia , lookup

Transformation (genetics) wikipedia , lookup

Real-time polymerase chain reaction wikipedia , lookup

Cell culture wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

List of types of proteins wikipedia , lookup

Transcript
The CRISPR-Cas technique has been used to generate gene knock-out in many
mammalian cell lines. Here, we showed detail protocols for generation of gene
knock-out in HEK-293T cells by transient transfection method and lentiviral
transduction method. The conditions may vary for different cell line(s).
1. Preparation of cells (for both plasmid transfection/virus transduction). Plate
HEK-293T cells onto 24-well plates in DMEM 16–24 hrs before transfection. Seed
the cells at a density of 1 × 105 cells per well in a total volume of 1 ml. (Note:
scale up or down according to different cell line as needed. Do not plate more
cells than the recommended density, as doing so may reduce
transfection/transduction efficiency.)
2-1. Plasmid transfection method. On the day of transfection, cells are optimal at
60–80% confluency. Cells should be transfected with optimal transfection
reagent (e.g., Lipofectamine 2000 or TransIT-LT1 for HEK-293T cells) according
to the manufacturers’ instructions and the transfection efficiency varies
according to cell type and the transfection reagent used. For cells with low
transfection efficiency, please use electroporation or virus transduction method
for plasmids delivery. Prepare 500 ng of plasmid for the expression of sgRNA(s)
and Cas9 protein for transfection (and 500 ng of surrogate reporter plasmid if
you are planning to use cell sorter to enrich the cell population with gene
editing). If you are transfecting more than one plasmid (for example, two vector
system for sgRNA and Cas9 expression), mix them at equimolar ratio and use no
more than 1 μg of total DNA. Control sgRNA might be used in the negative
control experiment if needed.
2-2. Lentiviral transduction method. In the case of lentiviral transduction method,
cells are optimal at 60–80% confluency on the day of transfection. For adherent
cells, cells should be spin-infected with lentivirus(es) expressing sgRNA and Cas9
in culture medium containing polybrene. The concentration of polybrene would
vary according to cell type and the regular concentration used in HEK-293T cells
and A549 cells is 8 μg/ml. For suspension cells, add lentivirus(es) into the culture
medium and both spin-infection and polbrene are not necessary for lentiviral
transduction. A lentivirus expressing control sgRNA might be used in the
negative control experiment if needed.
3-1. Antibiotic selection (for both plasmid transfection/virus transduction). At
16–24 hrs post-transfection/post-transduction, the culture medium should be
replaced with fresh medium containing puromycin to remove non-transfected/
non-infected cells. The working concentration of puromycin varies according to
different cell line used, e.g., the optimal concentration of puromycin for the
treatment of HEK-293T cells is 2–2.5 μg/ml. Incubate the cells for a total of
48–72 hrs post-transfection/post-transduction before passaging them for
downstream applications. After 3–7 days of puromycin selection, single cell
clones are isolated by limiting dilution into 96-well plates.
3-2. Enrichment population by cell sorter (for plasmid transfection only). There is an
alternative way to enrich the population of cells with gene editing by cell sorter.
A surrogate reporter has been demonstrated to be an effective and reliable tool
enabling one to selectively enrich genetically modified cells. In brief, at 72 hrs
post-transfection, the cells are harvested for cell sorting by indicated
fluorescence, e.g., mCherry fluorescence in our assay system. Antibiotic
selection is not necessary. For those cells with CRISPR/Cas9-mediated gene
editing, the mCherry fluorescent gene in the surrogate reporter may become
in-frame and then expressed. The mCherry is a monomeric fluorescent protein
with peak absorption/emission at 587 nm and 610 nm, respectively. Cells with
mCherry fluorescence will be collected by cell sorter to enrich the population of
cells with possible editing in the endogenous gene. After 3 days of recovery from
sorting, single cell clones are isolated by limiting dilution into 96-well plates.
4. Limiting dilution (for both plasmid transfection/virus transduction). The cell line
should tolerate being single cell diluted when plating 96-well plates at 1 cell per
well in standard cell culture media. To make sure single cell clones will be picked
up by this method, prepare cells by well trypsinization and resuspend cells into
DMEM in 50 ml conical bottom tubes with the cell density of 1 cell per ml. Mix
well then transfer diluted cells by dispensing 100 µl/well in all 12 columns of five
to ten 96-well plates using a multichannel pipette. Transfer 96-well plates to a
humidified incubator at 37oC with 5% CO2. Add 100 µl of fresh culture medium
every week and visually inspect the 96-well plates periodically from 7 to 14 days
under a microscope to assess if colonies are establishing. Note that only 5–10
colonies will be established in one 96-well plate. Expand and further culture those
cell colonies in 24-well or 12-well plates until the cell numbers are enough for
genomic DNA isolation (for genomic DNA PCR/sequencing) and protein extraction
(for western blot analysis). The remaining pooled cells could be used for T7E1
assay (for validation of NHEJ efficiency) or western blot analysis (for gene
knock-out analysis in pooled cells).
5. T7 Endonuclease I assay (for both plasmid transfection/virus transduction).
Pooled cells are harvested to isolate genomic DNA for T7E1 assay. Prepare
genomic DNA and setup a 50 μl PCR reaction by using 100 ng genomic DNA and
0.3 mM proper genomic PCR primers spanning the Cas9 cleavage site(s). The
DreamTaq Green from Thermo Scientific (#K1081) is recommended. After 40
cycles of PCR reaction, perform additional denaturation and reannealing in a PCR
machine to obtain the denatured/reannealed PCR products. Transfer 20 μl
denatured/reannealed PCR products to new PCR tubes and add 0.3 μl of T7E1
(NEB#M0302L) into each sample. Digest the denatured/reannealed PCR products
at 37oC for 40 min. (Note: Longer incubation time will result in non-specific
digestion.) The NHEJ efficacy could be analyzed by electrophoresis in a 2%
agarose gel.
6-1.Validation gene knock-out by western blot analysis (for both plasmid
transfection/virus transduction). If your antibody is good enough (with high
specificity), we highly recommend using western blot analysis to validate gene
knock-out phenotype among those single cell clones. Cell lysates prepared from
either single cell clones or pooled cells are separated on SDS-PAGE gels,
transferred onto nitrocellulose paper and incubated with primary antibodies. The
missing of specific band in the western blot indicates that the target gene has
been successfully knocked-out in the single cell clone. Two or more single cell
clones with gene knock-out phenotype should be picked-up and presented in one
set of experiment.
6-2.Validation gene knock-out by genomic DNA PCR/sequencing method (for both
plasmid transfection/virus transduction). Prepare genomic DNA and setup a 20 μl
PCR reaction by using 100 ng genomic DNA and 0.3 mM proper genomic PCR
primers spanning the Cas9 cleavage site(s). The DreamTaq Green from Thermo
Scientific (#K1081) is recommended. After 40 cycles of PCR reaction, check PCR
specificity by taking 5 μl of PCR product for electrophoresis in a 1% agarose gel.
After PCR clean-up, PCR product is ready for sequencing validation by using
proper sequencing primer. For PCR products from heterozygous genomic DNA
(heterozygous editing outcomes in different alleles), the PCR products should be
sub-cloned into a plasmid cloning vector for further sequencing validation.